Invus Global Management, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Tango Therapeutics, Inc. Common Stock, $0.001 par value per share (TNGX)

Filing Manager
Invus Global Management, LLC
Reporting Manager
Raymond Debbane
Security
Tango Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol
TNGX
Shares outstanding
133,858,590 shares
Disclosed Ownership
8,165,374 shares
Ownership
6.1%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2026, 11:47:30 UTC
Date of event
31 Dec 2025
Previous filing
22 Sep 2025
SEC
View on sec.gov

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Invus Public Equities, L.P. 5.3% 7,068,444 7,068,444 0 /s/ Raymond Debbane Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC 5.3% 7,068,444 7,068,444 0 /s/ Raymond Debbane Raymond Debbane, President
Invus Global Management, LLC 5.3% 7,068,444 7,068,444 0 /s/ Raymond Debbane Raymond Debbane, President
Siren, L.L.C. 5.3% 7,068,444 7,068,444 0 /s/ Raymond Debbane Raymond Debbane, President
Avicenna Life Sci Master Fund LP 0.8% 1,096,930 1,096,930 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner
Avicenna Life Sci Master GP LLC 0.8% 1,096,930 1,096,930 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer
Ulys, L.L.C. 0.8% 1,096,930 1,096,930 0 /s/ Raymond Debbane Raymond Debbane, President
Raymond Debbane 6.1% 8,165,374 8,165,374 0 /s/ Raymond Debbane Raymond Debbane